Third, multiple prediction models will be established based on the expression of PTP4A1 in CTCs to predict lymph node metastasis and efficacy of neoadjuvant therapy in patients with esophageal cancer. This evidence concerns the gene PTP4A1 and metastatic malignant neoplasm in the lymph nodes.